▪ Multiplied investments for clients from $1 million to over $10 million▪ Structured equity capital raises ranging from $1 million to $50 million for some stellar public and private companies▪ Raised funds under advisement by 100% in 3 years▪ Drove scaled growth across investments with a a fundamental long-short Equity portfolio and short term derivatives▪ Delivered active investment strategies across bitcoin futures and custom solutions to individual investors resulting in a 15% outperformance

▪ Managed 35 existing client accounts increasing business by up to 33% despite the slowdown in markets ▪ Ranked in the top 3 for the region on account of excellent alliances with fund managers and an extensive industry network▪ Researched and cultivated new business prospects, winning ten new hedge fund and pension fund clients ▪ Worked closely with Equity Research, Regional Sales and Syndicate to promote the franchise e.g. cross sell various products like Bonds

▪ Accelerated revenue from Global Institutional Clients (20%-300%); marketed Indian equity ideas▪ Improved ranking to top 3 with specific undervalued stock insights and local market knowledge▪ Organised a sizeable IT Sector Conference with participation from top 100 clients and top 30 firms resulting in enhanced visibility, strengthened relationships and improved rankings - revenue contribution expanded by over 50%▪ Re-initiated revenues from two large funds with top 10 billing and sourced five new clients increasing presence in Singapore

▪ Continually ranked amongst the top three by Bloomberg in Research (Indian Pharmaceutical Stocks) ▪ Achieved a 51% return on buy and sell recommendations, with 84% of recommendations posting a positive return, compared to a 26% return on the Nifty Pharma during the same period. ▪ Promoted to Senior Analyst within one month -- one of the youngest in the Industry ▪ Hosted a one-of-its-kind conference on an emerging influential industry trend -- CRAMS (Contract research and manufacturing services) that had a record participation from several FIIs and major domestic clients - added more than 15 FIIs as clients and helped empanelment of another 10

▪ Part of the top ranked (Institutional Investor) Large Cap EU Pharmaceutical Research Team ▪ Complete responsibility for several sectoral reports, involving analysis and identification of key trends that was sent to over 500 institutional clients▪ Built complex discounted cash flow models to produce potential valuations of companies, including initiation of coverage on stocks and a multi-billion euro M&A transaction.▪ Supported senior analysts - wrote regular and one-off reports; in-charge of all client queries and balance sheet projections